Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation

Published:2002-11-14 Issue:11 Volume:30 Page:785-792
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Epstein JB,Phillips N,Parry J,Epstein MS,Nevill T,Stevenson-Moore P

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1703716.pdf

Reference38 articles.

1. Gotay CC, Moore TD . Assessing quality of life in head and neck cancer Quality of Life Res 1992 1: 5 17

2. Sonis ST, Oster G, Fuchs H et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem cell transplantation J Clin Oncol 2001 19: 2201 2205

3. Bellm LA, Epstein JB, Rose-Ped A et al. Patient reports of complications of bone marrow transplantation Supp Care Cancer 2000 8: 33 39

4. Kopp M, Schweigkofler H, Holzner B et al. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment Ann Hematol 1998 77: 27 32

5. Neithammer D, Mayer E . Long-term survivors: an overview on late effects, sequelae and second neoplasias Bone Marrow Transplant 1998 21: (Suppl. 2) S61 S63

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Taste and Smell Alterations (TSAs) in Cancer Patients;Diseases;2024-06-19

2. Systematic Review of Dysgeusia Frequency Following Hematopoietic Stem Cell Transplant;EXP CLIN TRANSPLANT;2024

3. Survivorship;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

4. Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab;Supportive Care in Cancer;2023-12-14

5. The impact of treatment-induced dysgeusia on the nutritional status of cancer patients;Clinical Nutrition Open Science;2023-08